ANDA 75407, held by Dava Pharms Inc. Morphine Sulfate.
As of Nov 15, 2026, ANDA 75407 (Morphine Sulfate), held by Dava Pharms Inc, was first approved by FDA on Jan 28, 2000, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 28, 2000 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Morphine Sulfate15MG ยท tablet, extended release;oral | Morphine Sulfate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
